(Q38056159)

27 August 2017

title

A/H5N1 prepandemic influenza vaccine (Vepacel®): a guide to its use. (English)

1 reference

27 August 2017

1 reference

2

Greg L Plosker

1 reference

Katherine A Lyseng-Williamson

27 August 2017

series ordinal

3

object named as

Katherine A Lyseng-Williamson

1 reference

27 August 2017

1

Gillian M Keating

1 reference

27 August 2017

publication date

1 December 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

26

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

425-430

1 reference

Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11209740-000000000-00000

Vaccine preparedness--are we ready for the next influenza pandemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11209740-000000000-00000

Strategies for mitigating an influenza pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11209740-000000000-00000

A/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated) [Vepacel®].

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11209740-000000000-00000

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11209740-000000000-00000

Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11209740-000000000-00000

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11209740-000000000-00000

A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11209740-000000000-00000

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11209740-000000000-00000

Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11209740-000000000-00000

10.2165/11209740-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference